首站-论文投稿智能助手
典型文献
Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages
文献摘要:
Objective: Although great progress has been made in the field of siRNA gene therapy, safe, efficient, and targeted delivery of siRNA are still major challenges in siRNA therapeutics.Methods: We developed an up-conversion nanoparticle-based nanocage system. This system protected the siRNA from being degraded by nucleases in organisms and selectively delivered the siRNAs to the tumor sites, due to modifications of targeted molecules on the surfaces of nanocages and local inhalation. Results: The siRNAs delivered by the up-conversion nanoparticle nanocages were protected from degradation in transit to the tumor sites, where they accumulated. Compared with the passive target and control groups, the up-conversion nanoparticles based on the nanocage system showed a tumor suppressive effect after approximately 3 weeks of treatment. Conclusions: The up-conversion nanoparticle nanocages efficiently delivered vascular endothelial growth factor siRNAs to tumor sites. Mice with lung tumors treated with tumors targeting up-conversion nanoparticle nanocages showed steady body weight changes, high tumor inhibition ratios, and longer survival times.
文献关键词:
作者姓名:
Yu Han;Yuming Yang;Qiuyang Sun;Bin Li;Caixia Yue;Yanlei Liu;Jesús M.de la Fuente;Daxiang Cui
作者机构:
Institute of Nano Biomedicine and Engineering,Key Laboratory for Thin Film and Microfabrication Technology of the Ministry of Education,Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument,Department of Instrument Science&Engineering,School of Electronic Information and Electrical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;National Engineering Center for Nanotechnology,Collaborative Innovational Center for System Biology,Shanghai 200241,China;Department of Neurosurgery,Xinhua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200092,China;School of Biomedical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China;Instituto de Nanociencia de Aragon(INA),Universidad de Zaragoza,Zaragoza 50018,Spain
引用格式:
[1]Yu Han;Yuming Yang;Qiuyang Sun;Bin Li;Caixia Yue;Yanlei Liu;Jesús M.de la Fuente;Daxiang Cui-.Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages)[J].癌症生物学与医学(英文版),2022(07):1047-1060
A类:
B类:
Dual,targeted,lung,cancer,therapy,via,inhalation,delivery,UCNP,AS1411,nanocages,Objective,Although,great,progress,has,been,made,field,gene,safe,still,major,challenges,therapeutics,Methods,We,developed,conversion,system,This,protected,from,being,degraded,by,nucleases,organisms,selectively,delivered,siRNAs,sites,due,modifications,molecules,surfaces,local,Results,were,degradation,transit,where,they,accumulated,Compared,passive,control,groups,nanoparticles,showed,suppressive,effect,after,approximately,weeks,treatment,Conclusions,efficiently,vascular,endothelial,growth,Mice,tumors,treated,targeting,steady,body,weight,changes,high,inhibition,ratios,longer,survival,times
AB值:
0.543127
相似文献
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。